These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33951917)

  • 1. Sentinel lymph node in cervical cancer: time to move forward.
    Balaya V; Guani B; Pache B; Durand YG; Bonsang-Kitzis H; Ngô C; Mathevet P; Lécuru F
    Chin Clin Oncol; 2021 Apr; 10(2):18. PubMed ID: 33951917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sentinel lymph node biopsy in early-stage cervical cancer: current state of art].
    Balaya V; Guani B; Bonsang-Kitzis H; Deloménie M; Ngô C; Montero Macias R; Koual M; Nguyen-Xuan HT; Bats AS; Mathevet P; Lécuru F
    Bull Cancer; 2020 Jun; 107(6):696-706. PubMed ID: 31627905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indocyanine Green versus Radiotracer with or without Blue Dye for Sentinel Lymph Node Mapping in Stage >IB1 Cervical Cancer (>2 cm).
    Di Martino G; Crivellaro C; De Ponti E; Bussi B; Papadia A; Zapardiel I; Vizza E; Elisei F; Diestro MD; Locatelli L; Gasparri ML; Di Lorenzo P; Mueller M; Buda A
    J Minim Invasive Gynecol; 2017; 24(6):954-959. PubMed ID: 28571944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining Indocyanine Green and Tc
    Lührs O; Ekdahl L; Lönnerfors C; Geppert B; Persson J
    Gynecol Oncol; 2020 Feb; 156(2):335-340. PubMed ID: 31780237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer.
    Salvo G; Ramirez PT; Levenback CF; Munsell MF; Euscher ED; Soliman PT; Frumovitz M
    Gynecol Oncol; 2017 Apr; 145(1):96-101. PubMed ID: 28188015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739).
    Backes FJ; Cohen D; Salani R; Cohn DE; O'Malley DM; Fanning E; Suarez AA; Fowler JM
    Gynecol Oncol; 2019 Jun; 153(3):496-499. PubMed ID: 31230614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of frozen section examination of sentinel lymph nodes in early-stage cervical cancer at the time of ultrastaging.
    Balaya V; Guani B; Benoit L; Magaud L; Bonsang-Kitzis H; Ngô C; Le Frère-Belda MA; Mathevet P; Lécuru F
    Gynecol Oncol; 2020 Sep; 158(3):576-583. PubMed ID: 32595022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel lymph node (SLN) concept in cervical cancer: Current limitations and unanswered questions.
    Cibula D; McCluggage WG
    Gynecol Oncol; 2019 Jan; 152(1):202-207. PubMed ID: 30318103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel lymph node mapping and intraoperative assessment in a prospective, international, multicentre, observational trial of patients with cervical cancer: The SENTIX trial.
    Cibula D; Kocian R; Plaikner A; Jarkovsky J; Klat J; Zapardiel I; Pilka R; Torne A; Sehnal B; Ostojich M; Petiz A; Sanchez OA; Presl J; Buda A; Raspagliesi F; Kascak P; van Lonkhuijzen L; Barahona M; Minar L; Blecharz P; Pakiz M; Wydra D; Snyman LC; Zalewski K; Zorrero C; Havelka P; Redecha M; Vinnytska A; Vergote I; Tingulstad S; Michal M; Kipp B; Slama J; Marnitz S; Bajsova S; Hernandez A; Fischerova D; Nemejcova K; Kohler C
    Eur J Cancer; 2020 Sep; 137():69-80. PubMed ID: 32750501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph node biopsy in the management of early-stage cervical carcinoma.
    Diaz JP; Gemignani ML; Pandit-Taskar N; Park KJ; Murray MP; Chi DS; Sonoda Y; Barakat RR; Abu-Rustum NR
    Gynecol Oncol; 2011 Mar; 120(3):347-52. PubMed ID: 21216450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frozen section examination of sentinel lymph nodes can be used as a decisional tool in the surgical management of early cervical cancer.
    Rychlik A; Angeles MA; Migliorelli F; Croce S; Mery E; Martinez A; Ferron G; Guyon F; Querleu D
    Int J Gynecol Cancer; 2020 Mar; 30(3):358-363. PubMed ID: 31911532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of sentinel lymph node mapping with indocyanine green in cervical cancer.
    Kim JH; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    World J Surg Oncol; 2018 Mar; 16(1):52. PubMed ID: 29523141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel Node Mapping Using Indocyanine Green and Near-infrared Fluorescence Imaging Technology for Uterine Malignancies: Preliminary Experience With the Da Vinci Xi System.
    Siesto G; Romano F; Fiamengo B; Vitobello D
    J Minim Invasive Gynecol; 2016; 23(4):470-1. PubMed ID: 26767824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node low-volume metastasis in early-stage cervical cancer.
    Bizzarri N; Pedone Anchora L; Zannoni GF; Santoro A; Valente M; Inzani F; Gallotta V; Conte C; Chiantera V; Fanfani F; Fagotti A; Ferrandina G; Scambia G
    Int J Gynecol Cancer; 2020 Mar; 30(3):364-371. PubMed ID: 31980488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value and best way for detection of Sentinel lymph node in early stage endometrial cancer: Selective lymphadenectomy algorithm.
    El-Agwany AS; Meleis MH
    Eur J Obstet Gynecol Reprod Biol; 2018 Jun; 225():35-39. PubMed ID: 29660577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping sentinel lymph nodes in early-stage ovarian cancer (MELISA) trial - a further step towards lymphadenectomy replacement.
    Agustí N; Vidal-Sicart S; Paredes P; Celada-Castro C; Migliorelli F; Glickman A; Marina T; Fusté P; Carreras-Dieguez N; Saco A; Díaz-Feijóo B; Torné A
    Gynecol Oncol; 2023 Dec; 179():145-151. PubMed ID: 37980769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From Conventional Radiotracer Tc-99(m) with Blue Dye to Indocyanine Green Fluorescence: A Comparison of Methods Towards Optimization of Sentinel Lymph Node Mapping in Early Stage Cervical Cancer for a Laparoscopic Approach.
    Buda A; Papadia A; Zapardiel I; Vizza E; Ghezzi F; De Ponti E; Lissoni AA; Imboden S; Diestro MD; Verri D; Gasparri ML; Bussi B; Di Martino G; de la Noval BD; Mueller M; Crivellaro C
    Ann Surg Oncol; 2016 Sep; 23(9):2959-65. PubMed ID: 27126631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The sentinel node technique detects unexpected drainage pathways and allows nodal ultrastaging in early cervical cancer: insights from the multicenter prospective SENTICOL study.
    Bats AS; Mathevet P; Buenerd A; Orliaguet I; Mery E; Zerdoud S; Le Frère-Belda MA; Froissart M; Querleu D; Martinez A; Leblanc E; Morice P; Daraï E; Marret H; Gillaizeau F; Lécuru F
    Ann Surg Oncol; 2013 Feb; 20(2):413-22. PubMed ID: 22911367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study using indocyanine green and patent blue dye for sentinel lymph node biopsy in patients with early-stage cervical cancer.
    Wess B; Kohler C; Plaikner A; El-Safadi S; Schwandner T; Meinhold-Heerlein I; Favero G
    Int J Gynecol Cancer; 2024 May; 34(5):675-680. PubMed ID: 38485222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementing a Cervical Sentinel Lymph Node Biopsy Program: Quality Improvement in Gynaecologic Oncology.
    Cusimano MC; Walker R; Bernardini MQ; Bouchard-Fortier G; Laframboise S; May T; Murphy J; Rosen B; Covens A; Clarke B; Shaw P; Rouzbahman M; Mohan R; Ferguson SE
    J Obstet Gynaecol Can; 2017 Aug; 39(8):659-667. PubMed ID: 28729099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.